Enjoy complimentary customisation on priority with our Enterprise License!
The meningococcal vaccines market share should rise by USD 1.68 billion from 2021 to 2025 at a CAGR of 8.94%.
This meningococcal vaccines market research report provides valuable insights on the post COVID-19 impact on the market, which will help companies evaluate their business approaches. Furthermore, this report extensively covers market segmentation by composition (mono vaccines and combination vaccines) and geography (North America, Europe, Asia, and ROW). The meningococcal vaccines market report also offers information on several market vendors, including Baxter International Inc., Bio-Med Pvt. Ltd., GlaxoSmithKline Plc, Incepta Vaccine Ltd., Merck and Co. Inc., Novartis AG, Pfizer Inc., Sanofi SA, Serum Institute of India Pvt. Ltd., and Walvax Biotechnology Co. Ltd. among others.
To Unlock the Meningococcal Vaccines Market Size for 2021 and Other Important Statistics, Download the Free Report Sample!
The increase in the pediatric population is notably driving the meningococcal vaccines market growth, although factors such as a slowdown in the manufacturing industry may impede market growth. Our research analysts have studied the historical data and deduced the key market drivers and the COVID-19 pandemic impact on the meningococcal vaccines industry. The holistic analysis of the drivers will help in predicting end goals and refining marketing strategies to gain a competitive edge.
This meningococcal vaccines market analysis report also provides detailed information on other upcoming trends and challenges that will have a far-reaching effect on the market growth. The actionable insights on the trends and challenges will help companies evaluate and develop growth strategies for 2021-2025.
The report analyzes the market's competitive landscape and offers information on several market vendors, including:
The vendor landscape of the meningococcal vaccines market entails successful business strategies deployed by the vendors. The meningococcal vaccines market is fragmented and the vendors are deploying various organic and inorganic growth strategies to compete in the market.
To make the most of the opportunities and recover from post COVID-19 impact, market vendors should focus more on the growth prospects in the fast-growing segments, while maintaining their positions in the slow-growing segments.
Download a free sample of the meningococcal vaccines market forecast report for insights on complete key vendor profiles. The profiles include information on the production, sustainability, and prospects of the leading companies.
For more insights on the market share of various regions Request for a FREE sample now!
40% of the market's growth will originate from North America during the forecast period. The US, Mexico, and Canada are the key markets for meningococcal vaccines in North America.
The report offers an up-to-date analysis of the geographical composition of the market. North America has been recording a significant growth rate and is expected to offer several growth opportunities to market vendors during the forecast period. The initiatives from government agencies will facilitate the meningococcal vaccines market growth in North America over the forecast period. The report offers an up-to-date analysis of the geographical composition of the market, competitive intelligence, and regional opportunities in store for vendors.
To gain further insights on the market contribution of various segments Request for a FREE sample
The meningococcal vaccines market share growth by the mono vaccines segment has been significant. This report provides insights on the impact of the unprecedented outbreak of COVID-19 on market segments. Through these insights, you can safely deduce transformation patterns in consumer behavior, which is crucial to gauge segment-wise revenue growth during 2021-2025 and embrace technologies to improve business efficiency.
This report provides an accurate prediction of the contribution of all the segments to the growth of the meningococcal vaccines market size. Furthermore, our analysts have indicated actionable market insights on post COVID-19 impact on each segment, which is crucial to predict change in consumer demand.
|
Meningococcal Vaccines Market Scope |
|
|
Report Coverage |
Details |
|
Page number |
120 |
|
Base year |
2020 |
|
Forecast period |
2021-2025 |
|
Growth momentum & CAGR |
Accelerate at a CAGR of 8.94% |
|
Market growth 2021-2025 |
$ 1.68 billion |
|
Market structure |
Fragmented |
|
YoY growth (%) |
6.99 |
|
Regional analysis |
North America, Europe, Asia, and ROW |
|
Performing market contribution |
North America at 40% |
|
Key consumer countries |
US, Germany, Canada, China, UK, France, Japan, Mexico, and India |
|
Competitive landscape |
Leading companies, Competitive strategies, Consumer engagement scope |
|
Companies profiled |
Baxter International Inc., Bio-Med Pvt. Ltd., GlaxoSmithKline Plc, Incepta Vaccine Ltd., Merck and Co. Inc., Novartis AG, Pfizer Inc., Sanofi SA, Serum Institute of India Pvt. Ltd., and Walvax Biotechnology Co. Ltd. |
|
Market Dynamics |
Parent market analysis, Market growth inducers and obstacles, Fast-growing and slow-growing segment analysis, COVID-19 impact and future consumer dynamics, Market condition analysis for the forecast period |
|
Customization purview |
If our report has not included the data that you are looking for, you can reach out to our analysts and get segments customized. |
We can help! Our analysts can customize this report to meet your requirements. Get in touch
Executive Summary
Market Landscape
Market Sizing
Five Forces Analysis
Market Segmentation by Composition
Customer landscape
Geographic Landscape
Vendor Landscape
Vendor Analysis
Appendix
Research Framework
Technavio presents a detailed picture of the market by way of study, synthesis, and summation of data from multiple sources. The analysts have presented the various facets of the market with a particular focus on identifying the key industry influencers. The data thus presented is comprehensive, reliable, and the result of extensive research, both primary and secondary.
INFORMATION SOURCES
Primary sources
Secondary sources
DATA ANALYSIS
Data Synthesis
Data Validation
REPORT WRITING
Qualitative
Quantitative
Certified ISO 9001 : 2015
We are ISO 9001:2015 recognized that ensures quality services and product delivery to our clients.
We are GDPR and CCPA compliant! Your transaction & personal information is protected from unauthorized use.
Get lifetime access to our
Technavio Insights
Customized Report as per your Business Needs
Let us help you make report more suited to your requirements.
Get the report (PDF) sent to your email within minutes.
